DNAJB4/HLJ1 deficiency sensitizes diethylnitrosamine-induced hepatocarcinogenesis with peritumoral STAT3 activation

Buechel D, Sugiyama N, Rubinstein N, Saxena M, Kalathur RKR, Luond F, Vafaizadeh V, Valenta T, Hausmann G, Cantu C, Basler K, Christofori G. Parsing beta-catenin’s cell adhesion and Wnt signaling functions in malignant mammary tumor progression. Proc Natl Acad Sci U S A. 2021;118. https://doi.org/10.1073/pnas.2020227118

Chen CH, Chang WH, Su KY, Ku WH, Chang GC, Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, Yang PC, Chen JJ, Yu SL. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms. Oncogene. 2016;35:5674–85. https://doi.org/10.1038/onc.2016.106.

Article  CAS  PubMed  Google Scholar 

Chen X, Wang Y, Tao J, Shi Y, Gai X, Huang F, Ma Q, Zhou Z, Chen H, Zhang H, Liu Z, Sun Q, Peng H, Chen R, Jing Y, Yang H, Mao Y, Zhang H. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. Gastroenterology. 2015;149(741–52): e14. https://doi.org/10.1053/j.gastro.2015.05.005.

Article  CAS  Google Scholar 

Chen Y, Li J, Pu L, Hu J, Fang L, Zhou F, Zhang H, Yang Y, Rong X, Deng S, Hou L. DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway. Discov Oncol. 2023;14:144. https://doi.org/10.1007/s12672-023-00762-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collaborators GBDRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6

Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, Raubitschek A, Hoon DSB, Forman S, Figlin RA, Liu J, Jove R, Yu H. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell. 2012;21:642–54. https://doi.org/10.1016/j.ccr.2012.03.039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He L, Pratt H, Gao M, Wei F, Weng Z, Struhl K. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. eLife. 2021;10:e67312. https://doi.org/10.7554/eLife.67312

Hoe KL, Won M, Chung KS, Jang YJ, Lee SB, Kim DU, Lee JW, Yun JH, Yoo HS. Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver. Biochim Biophys Acta. 1998;1383:4–8.

Article  CAS  PubMed  Google Scholar 

Hora S, Wuestefeld T. Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives. Cells. 2023;12. https://doi.org/10.3390/cells12172129

Kakehashi A, Kato A, Inoue M, Ishii N, Okazaki E, Wei M, Tachibana T, Wanibuchi H. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions. Toxicol Appl Pharmacol. 2010;242:47–55. https://doi.org/10.1016/j.taap.2009.09.013.

Article  CAS  PubMed  Google Scholar 

Kamino H, Yamazaki Y, Saito K, Takizawa D, Kakizaki S, Moore R, Negishi M. Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors. Int J Oncol. 2011;38:1511–20. https://doi.org/10.3892/ijo.2011.980.

Article  CAS  PubMed  Google Scholar 

Kang JS, Wanibuchi H, Morimura K, Gonzalez FJ, Fukushima S. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res. 2007;67:11141–6. https://doi.org/10.1158/0008-5472.CAN-07-1369.

Article  CAS  PubMed  Google Scholar 

Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, Thorgeirsson SS. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet. 2004;36:1306–11. https://doi.org/10.1038/ng1481.

Article  CAS  PubMed  Google Scholar 

Lee JW, Stone ML, Porrett PM, Thomas SK, Komar CA, Li JH, Delman D, Graham K, Gladney WL, Hua X, Black TA, Chien AL, Majmundar KS, Thompson JC, Yee SS, O’Hara MH, Aggarwal C, Xin D, Shaked A, Gao M, Liu D, Borad MJ, Ramanathan RK, Carpenter EL, Ji A, de Beer MC, de Beer FC, Webb NR, Beatty GL. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249–52. https://doi.org/10.1038/s41586-019-1004-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, Chang GC, Chen JJ. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res. 2010;38:6148–58. https://doi.org/10.1093/nar/gkq412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liska DJ. The detoxification enzyme systems. Altern Med Rev. 1998;3:187–98.

CAS  PubMed  Google Scholar 

Liu Y, Zhou J, Zhang C, Fu W, Xiao X, Ruan S, Zhang Y, Luo X, Tang M. HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival. Int J Clin Exp Pathol. 2014;7:969–77.

PubMed  PubMed Central  Google Scholar 

Luo WJ, Cheng TY, Wong KI, Fang WH, Liao KM, Hsieh YT, Su KY. Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept. Eur J Pharm Sci. 2018;121:106–17. https://doi.org/10.1016/j.ejps.2018.05.018.

Article  CAS  PubMed  Google Scholar 

Luo W-J, Yu S-L, Chang C-C, Chien M-H, Chang Y-L, Liao K-M, Lin P-C, Chung K-P, Chuang Y-H, Chen JJW, Yang P-C, Su K-Y. HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages. eLife. 2022;11:e76094. https://doi.org/10.7554/eLife.76094

Memon A, Pyao Y, Jung Y, Lee JI, Lee WK. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma. Int J Mol Sci. 2020;21. https://doi.org/10.3390/ijms21155461

Miao W, Li L, Wang Y. A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis. Anal Chem. 2018;90:6835–42. https://doi.org/10.1021/acs.analchem.8b00986.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moya IM, Castaldo SA, Van den Mooter L, Soheily S, Sansores-Garcia L, Jacobs J, Mannaerts I, Xie J, Verboven E, Hillen H, Algueró-Nadal A, Karaman R, Van Haele M, Kowalczyk W, De Waegeneer M, Verhulst S, Karras P, van Huffel L, Zender L, Marine J-C, Roskams T, Johnson R, Aerts S, van Grunsven LA, Halder G. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029. https://doi.org/10.1126/science.aaw9886.

Article  CAS  PubMed  Google Scholar 

Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121–4. https://doi.org/10.1126/science.1140485.

Article  CAS  PubMed  Google Scholar 

Rachidi S, Sun S, Wu BX, Jones E, Drake RR, Ogretmen B, Cowart LA, Clarke CJ, Hannun YA, Chiosis G, Liu B, Li Z. Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis. J Hepatol. 2015;62:879–88. https://doi.org/10.1016/j.jhep.2014.11.010.

Article  CAS  PubMed  Google Scholar 

Ren N, Atyah M, Chen WY, Zhou CH. The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications. J Transl Med. 2017;15:110. https://doi.org/10.1186/s12967-017-1218-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, Karin M. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell. 2008;14:156–65. https://doi.org/10.1016/j.ccr.2008.06.016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen Y, Wang X, Liu Y, Singhal M, Gürkaşlar C, Valls AF, Lei Y, Hu W, Schermann G, Adler H, Yu FX, Fischer T, Zhu Y, Augustin HG, Schmidt T, de Almodóvar CR. STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis. Sci Signal. 2021;14:eabj8393. https://doi.org/10.1126/scisignal.abj8393

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–102. https://doi.org/10.1093/nar/gkx247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst. 2006;98:825–38. https://doi.org/10.1093/jnci/djj229.

Article  CAS  PubMed  Google Scholar 

Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, Chen JJ, Yang PC. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene. 2005;24:4081–93. https://doi.org/10.1038/sj.onc.1208573.

Article  CAS  PubMed  Google Scholar 

Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, Yuan W, Gu X, Hu J, Yang S. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Ther. 2024;9:236. https://doi.org/10.1038/s41392-024-01937-7.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif